Cumberland Pharmaceuticals Inc.

254 articles about Cumberland Pharmaceuticals Inc.

• Cumberland Pharmaceuticals Reports Double Digit Revenue Growth For The Fourth Consecutive Quarter

  8/9/2017

• Cumberland Pharmaceuticals To Announce Second Quarter 2017 Financial Results

  8/2/2017

• Cumberland Pharmaceuticals Begins U.S. Shipments Of Dexrazoxane For Oncology Patient Support

  7/31/2017

• Clinigen And Cumberland Pharmaceuticals Obtain FDA Approval For Totect In The U.S.

  7/10/2017

• Cumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017

  5/16/2017

• Cumberland Pharmaceuticals To Announce First Quarter 2017 Financial Results

  5/9/2017

• Cumberland Pharmaceuticals Release: New Kristalose Growth Driver Established Through Co-Promotion Agreement

  4/26/2017

• Cumberland Pharmaceuticals Release: Caldolor Demonstrates Significant Post Surgical Pain Reduction And Decrease In Opioid Use

  3/28/2017

• Cumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results

  3/8/2017

• Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2016 Financial Results

  3/1/2017

• Cumberland Pharmaceuticals Release: Caldolor Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics

  2/7/2017

• U.S. Court Of Appeals Affirms Cumberland Pharmaceuticals' Victory In Patent Litigation Case

  1/30/2017

• Cumberland Pharmaceuticals Release: Company Announces Kenneth J. Krogulski To Join Its Board Of Directors

  1/16/2017

• Cumberland Pharmaceuticals And Clinigen Enter Exclusive U.S. Commercialization Agreement For Totect

  1/9/2017

• Cumberland Pharmaceuticals Acquires U.S. Rights To Nordic Group's Methotrexate Injection Products

  11/16/2016

• Cumberland Pharmaceuticals Reports Third Quarter & Year To Date 2016 Financial Results

  11/2/2016

• Cumberland Pharmaceuticals To Announce Third Quarter 2016 Financial Results

  10/26/2016

• Clinigen And Cumberland Pharmaceuticals Launch Ethyol In The U.S.

  9/27/2016

• Cumberland Pharmaceuticals Launches Promotion Of Ethyol In The United States For Oncology Patient Support

  9/26/2016

• Cumberland Pharmaceuticals Announces New Program To Develop Portaban For Portal Hypertension

  9/15/2016